JP2023549849A5 - - Google Patents
Info
- Publication number
- JP2023549849A5 JP2023549849A5 JP2023528620A JP2023528620A JP2023549849A5 JP 2023549849 A5 JP2023549849 A5 JP 2023549849A5 JP 2023528620 A JP2023528620 A JP 2023528620A JP 2023528620 A JP2023528620 A JP 2023528620A JP 2023549849 A5 JP2023549849 A5 JP 2023549849A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- solvate
- pharmaceutically acceptable
- acceptable salt
- angioedema
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20207273 | 2020-11-12 | ||
| EP20207273.2 | 2020-11-12 | ||
| PCT/EP2021/081493 WO2022101395A1 (en) | 2020-11-12 | 2021-11-12 | Prophylaxis and treatment of angioedema |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549849A JP2023549849A (ja) | 2023-11-29 |
| JP2023549849A5 true JP2023549849A5 (cg-RX-API-DMAC7.html) | 2024-11-18 |
Family
ID=73401436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528620A Pending JP2023549849A (ja) | 2020-11-12 | 2021-11-12 | 血管性浮腫の予防および処置 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230338358A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4243824B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023549849A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230107269A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116685353A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021376885A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3198246A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3061585T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302887A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023005563A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022101395A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202305122B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3062067T3 (en) * | 2022-03-25 | 2026-04-08 | Pharvaris Gmbh | Solid composition comprising solubilised bradykinin b2-receptor antagonists |
| TW202345810A (zh) * | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
| WO2025037920A1 (ko) | 2023-08-16 | 2025-02-20 | 주식회사 엘지화학 | 수지 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005053660A2 (en) * | 2003-12-03 | 2005-06-16 | Lifecycle Pharma A/S | Pharmaceutical compositions comprising danazol |
| US7816383B1 (en) * | 2009-12-04 | 2010-10-19 | Intermune, Inc. | Methods of administering pirfenidone therapy |
| AR113839A1 (es) * | 2017-11-24 | 2020-06-17 | Pharvaris B V | Antagonistas del receptor b2 de bradiquinina |
-
2021
- 2021-11-12 CN CN202180080857.7A patent/CN116685353A/zh active Pending
- 2021-11-12 IL IL302887A patent/IL302887A/en unknown
- 2021-11-12 MX MX2023005563A patent/MX2023005563A/es unknown
- 2021-11-12 KR KR1020237018410A patent/KR20230107269A/ko active Pending
- 2021-11-12 JP JP2023528620A patent/JP2023549849A/ja active Pending
- 2021-11-12 ES ES21805547T patent/ES3061585T3/es active Active
- 2021-11-12 AU AU2021376885A patent/AU2021376885A1/en active Pending
- 2021-11-12 WO PCT/EP2021/081493 patent/WO2022101395A1/en not_active Ceased
- 2021-11-12 EP EP21805547.3A patent/EP4243824B1/en active Active
- 2021-11-12 CA CA3198246A patent/CA3198246A1/en active Pending
- 2021-11-12 US US18/036,719 patent/US20230338358A1/en active Pending
-
2023
- 2023-05-09 ZA ZA2023/05122A patent/ZA202305122B/en unknown